Skip to content
Triangle logo TriangleGet started
← Lung Carcinoma

NCT01567722 · STUDY IN CONTEXT

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.

Read the full study record and all posted results →

Linked outcomes

Measures are not ranked. Open each original source section for treatment groups, denominators, units and results.

primary · POSTED

Summary of the specimens available by study arm

Source null

→

Reported safety

Serious events are not the same as severe events. Compare the original safety groups and their at-risk populations.

Open the study safety table →

Quality of life and patient-reported measures

No linked quality-of-life measure is recorded for this setting and study.

Full draft applicability and source-link record
trial
release id
clinical-indications-draft-1
disease state id
ds-lung-carcinoma
nct id
NCT01567722
trial label
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
applicability
narrower
applicability note
Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded.
curation status
draft
reviewed by
Source null
reviewed at
Source null
created at
2026-09-10T00:00:00Z
provenance class
registry-condition-search
discovery note
Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
outcome Count
1
harms Count
3
qol Count
0
outcomes
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    outcome key
    om-0000
    source section id
    NCT01567722-om-0000
    source outcome index
    0
    endpoint
    Collection of Tissue Specimen From Study Participants
    endpoint definition
    Summary of the specimens available by study arm
    time origin
    Study entry (prior to chemotherapy initiation)
    analysis role
    primary
    reporting status
    POSTED
    data cutoff
    Source null
    population note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
arms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    outcome key
    om-0000
    arm key
    OG000
    arm label
    HIV-positive Diffuse Large B-cell Lymphoma Cases
    regimen
    Tissue collection for genomic sequencing from persons with a diagnosis of HIV and diffuse large B-cell lymphoma.
    analyzed count
    93
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT01567722-om-0000#groups/OG000
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    outcome key
    om-0000
    arm key
    OG001
    arm label
    HIV-positive Lung Cancer Cases
    regimen
    Tissue collection for genomic sequencing from persons with a diagnosis of HIV and lung cancer.
    analyzed count
    19
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT01567722-om-0000#groups/OG001
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    outcome key
    om-0000
    arm key
    OG002
    arm label
    HIV Positive Cervical Cancer Cases
    regimen
    Tissue collection for genomic sequencing from persons with a diagnosis of HIV and cervical cancer.
    analyzed count
    2
    analyzed unit
    Participants
    is comparator
    Source null
    source pointer
    NCT01567722-om-0000#groups/OG002
harms
  1. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    harm key
    EG000
    source section id
    NCT01567722-ae
    event group key
    EG000
    event group label
    HIV-positive Diffuse Large B-cell Lymphoma Cases
    serious affected
    0
    serious at risk
    0
    other affected
    0
    other at risk
    0
    frequency threshold
    0
    collection period
    Adverse events data was not collected for this study..
    event definition
    As a laboratory study involving only sample collection through routine clinical care and data abstraction, no adverse events was collected for this study.
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  2. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    harm key
    EG001
    source section id
    NCT01567722-ae
    event group key
    EG001
    event group label
    HIV-positive Lung Cancer Cases
    serious affected
    0
    serious at risk
    0
    other affected
    0
    other at risk
    0
    frequency threshold
    0
    collection period
    Adverse events data was not collected for this study..
    event definition
    As a laboratory study involving only sample collection through routine clinical care and data abstraction, no adverse events was collected for this study.
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
  3. release id
    clinical-indications-draft-1
    disease state id
    ds-lung-carcinoma
    nct id
    NCT01567722
    harm key
    EG002
    source section id
    NCT01567722-ae
    event group key
    EG002
    event group label
    HIV Positive Cervical Cancer Cases
    serious affected
    0
    serious at risk
    0
    other affected
    0
    other at risk
    0
    frequency threshold
    0
    collection period
    Adverse events data was not collected for this study..
    event definition
    As a laboratory study involving only sample collection through routine clinical care and data abstraction, no adverse events was collected for this study.
    undenominated note
    Source null
    curation status
    draft
    reviewed by
    Source null
    reviewed at
    Source null
    created at
    2026-09-10T00:00:00Z
quality of life
    setting source links

      Preserved source evidence · Not medical advice